000 01229 a2200337 4500
005 20250516220623.0
264 0 _c20150313
008 201503s 0 0 eng d
022 _a1744-8301
024 7 _a10.2217/fon.13.277
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKhan, Meaghan L
245 0 0 _aImmunotherapeutic and oncolytic viral therapeutic strategies in pancreatic cancer.
_h[electronic resource]
260 _bFuture oncology (London, England)
_cMay 2014
300 _a1255-75 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdenocarcinoma
_ximmunology
650 0 4 _aAnimals
650 0 4 _aClinical Trials, Phase I as Topic
650 0 4 _aClinical Trials, Phase II as Topic
650 0 4 _aDrug Evaluation, Preclinical
650 0 4 _aHumans
650 0 4 _aImmunotherapy
_xmethods
650 0 4 _aOncolytic Virotherapy
_xmethods
650 0 4 _aOncolytic Viruses
_xphysiology
650 0 4 _aPancreatic Neoplasms
_ximmunology
700 1 _aHalfdanarson, Thorvardur R
700 1 _aBorad, Mitesh J
773 0 _tFuture oncology (London, England)
_gvol. 10
_gno. 7
_gp. 1255-75
856 4 0 _uhttps://doi.org/10.2217/fon.13.277
_zAvailable from publisher's website
999 _c23935884
_d23935884